Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of $5.55 billion. The enterprise value is $5.10 billion.

Market Cap	5.55B
Enterprise Value	5.10B

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Legend Biotech has 193.44 million shares outstanding. The number of shares has increased by 0.75% in one year.

Current Share Class	n/a
Shares Outstanding	193.44M
Shares Change (YoY)	+0.75%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	50.42%
Float	82.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	37.75
PS Ratio	4.87
Forward PS	3.60
PB Ratio	5.51
P/TBV Ratio	5.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.40.

Current Ratio	2.13
Quick Ratio	2.01
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.41

Financial Efficiency

Return on equity (ROE) is -25.19% and return on invested capital (ROIC) is -27.20%.

Return on Equity (ROE)	-25.19%
Return on Assets (ROA)	-5.24%
Return on Invested Capital (ROIC)	-27.20%
Return on Capital Employed (ROCE)	-12.38%
Weighted Average Cost of Capital (WACC)	6.06%
Revenue Per Employee	$384,148
Profits Per Employee	-$84,351
Employee Count	2,965
Asset Turnover	0.71
Inventory Turnover	15.07

Taxes

In the past 12 months, Legend Biotech has paid $13.60 million in taxes.

Income Tax	13.60M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.18% in the last 52 weeks. The beta is 0.35, so Legend Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-14.18%
50-Day Moving Average	28.55
200-Day Moving Average	25.57
Relative Strength Index (RSI)	45.14
Average Volume (20 Days)	3,627,440

Short Selling Information

The latest short interest is 12.99 million, so 17.10% of the outstanding shares have been sold short.

Short Interest	12.99M
Short Previous Month	12.57M
Short % of Shares Out	17.10%
Short % of Float	n/a
Short Ratio (days to cover)	5.37

Income Statement

In the last 12 months, Legend Biotech had revenue of $1.14 billion and -$250.10 million in losses. Loss per share was -$1.38.

Revenue	1.14B
Gross Profit	626.30M
Operating Income	-134.60M
Pretax Income	-236.50M
Net Income	-250.10M
EBITDA	-125.10M
EBIT	-134.60M
Loss Per Share	-$1.38

Full Income Statement

Balance Sheet

The company has $834.60 million in cash and $389.30 million in debt, giving a net cash position of $445.30 million or $2.30 per share.

Cash & Cash Equivalents	834.60M
Total Debt	389.30M
Net Cash	445.30M
Net Cash Per Share	$2.30
Equity (Book Value)	967.70M
Book Value Per Share	5.21
Working Capital	573.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.70 million and capital expenditures -$34.10 million, giving a free cash flow of -$115.80 million.

Operating Cash Flow	-81.70M
Capital Expenditures	-34.10M
Depreciation & Amortization	9.50M
Net Borrowing	-4.10M
Free Cash Flow	-115.80M
FCF Per Share	-$0.60

Full Cash Flow Statement

Margins

Gross margin is 54.99%, with operating and profit margins of -11.82% and -21.96%.

Gross Margin	54.99%
Operating Margin	-11.82%
Pretax Margin	-20.76%
Profit Margin	-21.96%
EBITDA Margin	-10.98%
EBIT Margin	-11.82%
FCF Margin	n/a

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.75%
Shareholder Yield	-0.75%
Earnings Yield	-4.51%
FCF Yield	-2.09%

Analyst Forecast

The average price target for Legend Biotech is $57.43, which is 100.17% higher than the current price. The consensus rating is "Buy".

Price Target	$57.43
Price Target Difference	100.17%
Analyst Consensus	Buy
Analyst Count	15
Revenue Growth Forecast (3Y)	26.93%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Legend Biotech has an Altman Z-Score of 4.27 and a Piotroski F-Score of 2.

Altman Z-Score	4.27
Piotroski F-Score	2